China NMPA Drug Inspection - Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. - Oral rehydration salts (I)
China NMPA drug inspection for Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. published April 05, 2017. Drug: Oral rehydration salts (I). The Fujian Province Drug Quality Announcement, Issue No. 64, published on April 5, 2017, reported findings from a provin
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. published April 05, 2017. Drug: Oral rehydration salts (I). The Fujian Province Drug Quality Announcement, Issue No. 64, published on April 5, 2017, reported findings from a provin
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox